ARS Pharmaceuticals, Inc. - COM (SPRY)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
59.7 M
Holdings value Q1 2024
$610 M
Value change Q1 2024
-$15.8 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
111
Number of buys Q1 2024
63
Number of sells Q1 2024
-37
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
82835W108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 59.7 M $610 M -$15.8 M $10.22 112
2023 Q4 65.3 M $358 M -$3 M $5.48 97
2023 Q3 66.5 M $251 M +$40.3 M $3.78 95
2023 Q2 54.8 M $367 M +$9.83 M $6.70 92
2023 Q1 53.4 M $348 M +$19.4 M $6.51 87
2022 Q4 50.2 M $428 M +$173 M $8.53 72
2022 Q3 30.4 M $160 M +$25 M $5.28 57
2022 Q2 25.9 M $110 M -$872 K $4.24 58
2022 Q1 27 M $94.7 M -$19.3 M $3.51 65
2021 Q4 30.1 M $200 M -$13.2 M $6.66 72
2021 Q3 28.9 M $288 M -$42.5 M $9.98 74
2021 Q2 28 M $865 M -$827 K $30.89 74
2021 Q1 27.7 M $1.21 B +$139 M $43.63 66
2020 Q4 24.4 M $1.13 B +$1.12 B $46.34 60